Quetiapine Impurity 33 | CAS 50900-50-0 - Request Quote
Quetiapine Impurity 33
| SZ CAT No: | SZ-Q001092 |
| CAS No | 50900-50-0 |
| Mol.F. | C13H11NO2S |
| Mol.Wt. | 245.3 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 21221-56-7 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Quetiapine Impurity 33 is chemically 2-((4-Aminophenyl)thio)benzoic acid. Quetiapine Impurity 33 is supplied with detailed characterization data compliant with regulatory guideline. Quetiapine Impurity 33 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Quetiapine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 50900-50-0
Purchase 50900-50-0
Order 50900-50-0
Enquire 50900-50-0
price of 50900-50-0
50900-50-0 Supplier
50900-50-0 Manufacturer
50900-50-0 Exporter
buy high quality Quetiapine Impurity 33
Purchase Quetiapine Impurity 33
Quetiapine Impurity 33 suppliers
Quetiapine Impurity 33 manufacturers
Quetiapine Impurity 33 price
Order Quetiapine Impurity 33
Enquire Quetiapine Impurity 33
Quetiapine Impurity 33 cost
Quetiapine Impurity 33 Supplier
Quetiapine Impurity 33 Distributor
Quetiapine Impurity 33 for Method Validation
Quetiapine Reference Standard
Quetiapine Impurity 33 for ANDA Filing
Quetiapine Impurity 33 for Forced Degradation Studies
Quetiapine Impurity 33 Identification Standards
Quetiapine Impurity 33 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.